Raymond Anderson insider trades: Monopar Therapeutics (MNPR) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Raymond reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 2, 2026 | MNPR | ↓ Sell | 3,142 | $68.35 | $215K | Direct | Nov 4, 2026 (2d) |
| Aug 25, 2026 | MNPR | ↓ Sell | 3,142 | $111.98 | $352K | Direct | Aug 28, 2026 (3d) |
| Aug 25, 2026 | MNPR | ↓ Sell | 3,142 | $111.77 | $351K | Direct | Aug 27, 2026 (2d) |
| Sep 2, 2015 | RPTP | ↓ Sell | 4,916 | $12.51 | $61K | Direct | Sep 4, 2015 (2d) |
| Aug 31, 2015 | RPTP | ↓ Sell | 8,084 | $12.52 | $101K | Direct | Sep 2, 2015 (2d) |
| Mar 24, 2015 | RPTP | ↓ Sell | 21,619 | $12.00 | $259K | Direct | Mar 26, 2015 (2d) |
| Jan 12, 2015 | RPTP | ↓ Sell | 10,000 | $10.57 | $106K | Direct | Jan 14, 2015 (2d) |
| Sep 10, 2014 | RPTP | ↓ Sell | 10,000 | $10.81 | $108K | Direct | Sep 12, 2014 (2d) |
| Jul 7, 2014 | RPTP | ↓ Sell | 27,500 | $11.21 | $308K | Direct | Jul 9, 2014 (2d) |
| Mar 7, 2014 | RPTP | ↓ Sell | 12,500 | $15.72 | $197K | Direct | Mar 11, 2014 (4d) |
| Jan 7, 2014 | RPTP | ↓ Sell | 10,000 | $13.25 | $133K | Direct | Jan 9, 2014 (2d) |
| Nov 7, 2013 | RPTP | ↓ Sell | 15,000 | $14.04 | $211K | Direct | Nov 12, 2013 (5d) |
| Sep 9, 2013 | RPTP | ↓ Sell | 15,000 | $14.24 | $214K | Direct | Sep 11, 2013 (2d) |
| Dec 28, 2012 | RPTP | ↓ Sell | 2,000 | $5.50 | $11K | Direct | Dec 31, 2012 (3d) |
| Oct 1, 2012 | RPTP | ↓ Sell | 2,000 | $5.58 | $11K | Direct | Oct 1, 2012 (0d) |
| Sep 12, 2012 | RPTP | ↓ Sell | 2,000 | $5.50 | $11K | Direct | Sep 14, 2012 (2d) |
| Jun 8, 2012 | RPTP | ↓ Sell | 1,965 | $5.50 | $11K | Direct | Jun 11, 2012 (3d) |
| Jun 7, 2012 | RPTP | ↓ Sell | 35 | $5.50 | $193 | Direct | Jun 11, 2012 (4d) |
| Apr 2, 2012 | RPTP | ↓ Sell | 6,128 | $6.72 | $41K | Direct | Apr 4, 2012 (2d) |
| Feb 28, 2012 | RPTP | ↓ Sell | 6,128 | $7.29 | $45K | Direct | Mar 1, 2012 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other MNPR insiders
Open-market trades in the last 12 months
About Raymond Anderson's insider trades
Raymond Anderson is a director at Monopar Therapeutics (MNPR). Since Feb 28, 2012, Raymond has reported no open-market purchases and 20 sales worth $2.7M on SEC Form 4. In the last 12 months: 3 sales ($918K).
Their filings also include option exercises (34 filings), grants and awards (19 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.